Mitotane Other

Mitotane operates as a specialized adrenolytic agent that synergistically disrupts mitochondrial function and steroidogenesis to provide a comprehensive cytotoxic response against malignant adrenocortical cells. This unique delivery system is engineered to enhance the drug’s complex pharmacokinetic profile, facilitating more consistent intestinal absorption and reducing the incidence of dose-limiting gastrointestinal adverse effects. By maintaining steady-state plasma concentrations within a narrow therapeutic window, this formulation optimizes clinical outcomes and patient tolerability in the management of advanced adrenocortical carcinoma.